| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30087724 | HIV | ENSG00000108878.5 | protein_coding | CACNG1 | No | No | 786 | Q06432 |
| TVIS30044813 | HIV | ENSG00000108878.5 | protein_coding | CACNG1 | No | No | 786 | Q06432 |
| TVIS20036507 | HPV | ENSG00000108878.5 | protein_coding | CACNG1 | No | No | 786 | Q06432 |
| TVIS44023880 | HTLV-1 | ENSG00000108878.5 | protein_coding | CACNG1 | No | No | 786 | Q06432 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CACNG1 |
|---|---|
| DrugBank ID | DB00343 |
| Drug Name | Diltiazem |
| Target ID | BE0000679 |
| UniProt ID | Q06432 |
| Regulation Type | blocker |
| PubMed IDs | 19929811; 15320693 |
| Citations | Budriesi R, Ioan P, Carosati E, Cruciani G, Zhorov BS, Chiarini A: Ligands of diltiazem binding site: an overview of some chemotypes. Mini Rev Med Chem. 2009 Oct;9(12):1379-88.@@Romero M, Sanchez I, Pujol MD: New advances in the field of calcium channel antagonists: cardiovascular effects and structure-activity relationships. Curr Med Chem Cardiovasc Hematol Agents. 2003 Jun;1(2):113-41. |
| Groups | Approved; Investigational |
| Direct Classification | Benzothiazepines |
| SMILES | COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O |
| Pathways | Diltiazem Action Pathway |
| PharmGKB | PA449334 |
| ChEMBL | CHEMBL23 |
